Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.
Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of Taurolock-hep500™ as anticoagulant and antimicrobial catheter lock
solution in comparison to unfractionated heparin as alock solution to improve performance of
hemodialysis catheters and quality of hemodialysis .